We evaluated the efficacy of measurement of CD 34
+ cells in peripheral blood (PB) before leukapheresis (LA). Forty-five patients with malignant diseases underwent 65 LAs for collection of peripheral blood progenitor cells (PBPC). Median values for white blood cells (WBC), mononuclear cells (MNC) and CD 34
+ cells in PB before LA were 18, 900/μl, 3, 110/vl and 39.6/μl, respectively. Median values for CD 34
+ cells, colony forming unit-granulocyte/macrophage (CFU-GM) and total colony forming cells (CFC) in LA products were 3.19×10
6/kg, 5.7×10
5/kg and 12.90×10
5/kg, respectively. The strong correlation between CD 34
+ cells and CFU-GM or CFC (r=0.88 and 0.87) indicates that the number of CD 34
+ cells represents clonogenic activity. Regression analysis revealed a very strong correlation between CD 34
+ cells in LA products (Y) and those in PB before LA (X) (r=0.97, Y=5.43×10
5X-37.2×10
5), while only a weak correlation was seen between CD 34
+ cells in LA products and the number of WBC and MNC in PB before LA (r=0.60 and 0.56). These results indicated that the number of CD 34
+ cells in PB before LA can accurately predict that in LA products. We therefore conclude that the measurement of CD 34
+ cells in PB before LA is useful in the collection of PBPC with LA.
抄録全体を表示